Cukrzyca (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cukrzyca" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
1st place
1st place
347th place
4th place
low place
low place
2,374th place
2,071st place
low place
763rd place
8,738th place
165th place
low place
5,493rd place
5th place
2nd place
low place
low place
7,878th place
5,154th place
low place
low place

cukrzyca.info.pl

diabetesjournals.org

care.diabetesjournals.org

discoveryofinsulin.com

doi.org

doi.org

  • Kristina I Rother. Diabetes Treatment – Bridging the Divide. „N Engl J Med”. 356 (15), s. 1499-1501, April 2007. DOI: 10.1056/NEJMp078030. 
  • Walley AJ, Blakemore AI, Froguel P. Genetics of obesity and the prediction of risk for health. „Hum. Mol. Genet.”. 15 Spec No 2, s. R124-30, 2006. DOI: 10.1093/hmg/ddl215. PMID: 16987875. 
  • Barrett TG. Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. „Best Pract. Res. Clin. Endocrinol. Metab.”. 15 (3), s. 325-43, 2001. DOI: 10.1053/beem.2001.0149. PMID: 11554774. 
  • Daneman D. Type 1 diabetes. „Lancet”. 367 (9513), s. 847-58, May 2006. DOI: 10.1016/S0140-6736(06)68341-4. PMID: 16530579. 
  • Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.. „Lancet”. 368 (9548), s. 1673–9, 2006. DOI: 10.1016/S0140-6736(06)69701-8. PMID: 17098085. 
  • Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.. „N Engl J Med”. 346 (6), s. 393–403, 2002. DOI: 10.1056/NEJMoa012512. PMID: 11832527. PMCID: PMC1370926. 
  • Nutrition Recommendations and Interventions for Diabetes–2006. „Diabetes Care”. 29 (9), s. 2140-57, Sep 2006. American Diabetes Association. DOI: 10.2337/dc06-9914. 
  • Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. „Lancet”. 368 (9541), s. 1096–105, 2006. DOI: 10.1016/S0140-6736(06)69420-8. PMID: 16997664. 
  • Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.. „J Hypertens”. 24 (7), s. 1405–1412, 2006. DOI: 10.1097/01.hjh.0000234122.55895.5b. PMID: 16794491. 
  • Wasko MC, Hubert HB, Lingala VB, et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. „JAMA”. 298 (2), s. 187-93, 2007. DOI: 10.1001/jama.298.2.187. PMID: 17622600. 
  • Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. „JAMA”. 294 (20), s. 2601–10, 2005. DOI: 10.1001/jama.294.20.2601. PMID: 16304074. 
  • V. Chatsudthipong, C. Muanprasat. Stevioside and related compounds: therapeutic benefits beyond sweetness.. „Pharmacol Ther”. 121 (1), s. 41-54, Jan 2009. DOI: 10.1016/j.pharmthera.2008.09.007. PMID: 19000919. 
  • Maurice J. O'Kane, Brendan Bunting, Margaret Copeland, Vivien E. Coates i inni. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.. „BMJ”. 336 (7654), s. 1174-1177, May 2008. DOI: 10.1136/bmj.39534.571644.BE. PMID: 18420662. PMCID: PMC2394643. 

dx.doi.org

  • Christian Bommer i inni, The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study, „The Lancet Diabetes & Endocrinology”, 2017, DOI10.1016/S2213-8587(17)30097-9.

mp.pl

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • Walley AJ, Blakemore AI, Froguel P. Genetics of obesity and the prediction of risk for health. „Hum. Mol. Genet.”. 15 Spec No 2, s. R124-30, 2006. DOI: 10.1093/hmg/ddl215. PMID: 16987875. 
  • Barrett TG. Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. „Best Pract. Res. Clin. Endocrinol. Metab.”. 15 (3), s. 325-43, 2001. DOI: 10.1053/beem.2001.0149. PMID: 11554774. 
  • Daneman D. Type 1 diabetes. „Lancet”. 367 (9513), s. 847-58, May 2006. DOI: 10.1016/S0140-6736(06)68341-4. PMID: 16530579. 
  • Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis. „Lancet”. 2 (8411), s. 1083-6, 1984. PMID: 6150150. 
  • Virtanen S, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. „Am J Clin Nutr”. 78 (6), s. 1053-67, 2003. PMID: 14668264. 
  • Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.. „Lancet”. 368 (9548), s. 1673–9, 2006. DOI: 10.1016/S0140-6736(06)69701-8. PMID: 17098085. 
  • Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.. „N Engl J Med”. 346 (6), s. 393–403, 2002. DOI: 10.1056/NEJMoa012512. PMID: 11832527. PMCID: PMC1370926. 
  • Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. „Lancet”. 368 (9541), s. 1096–105, 2006. DOI: 10.1016/S0140-6736(06)69420-8. PMID: 16997664. 
  • Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.. „J Hypertens”. 24 (7), s. 1405–1412, 2006. DOI: 10.1097/01.hjh.0000234122.55895.5b. PMID: 16794491. 
  • Wasko MC, Hubert HB, Lingala VB, et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. „JAMA”. 298 (2), s. 187-93, 2007. DOI: 10.1001/jama.298.2.187. PMID: 17622600. 
  • Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. „JAMA”. 294 (20), s. 2601–10, 2005. DOI: 10.1001/jama.294.20.2601. PMID: 16304074. 
  • R. Abudula, PB. Jeppesen, SE. Rolfsen, J. Xiao i inni. Rebaudioside A potently stimulates insulin secretion from isolated mouse islets: studies on the dose-, glucose-, and calcium-dependency.. „Metabolism”. 53 (10), s. 1378-81, Oct 2004. PMID: 15375798. 
  • PB. Jeppesen, S. Gregersen, CR. Poulsen, K. Hermansen. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity.. „Metabolism”. 49 (2), s. 208-14, Feb 2000. PMID: 10690946. 
  • V. Chatsudthipong, C. Muanprasat. Stevioside and related compounds: therapeutic benefits beyond sweetness.. „Pharmacol Ther”. 121 (1), s. 41-54, Jan 2009. DOI: 10.1016/j.pharmthera.2008.09.007. PMID: 19000919. 
  • Maurice J. O'Kane, Brendan Bunting, Margaret Copeland, Vivien E. Coates i inni. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.. „BMJ”. 336 (7654), s. 1174-1177, May 2008. DOI: 10.1136/bmj.39534.571644.BE. PMID: 18420662. PMCID: PMC2394643. 
  • David F. Horrobin. Fatty acid metabolism in health and disease: the role of Δ-6-desaturase. „American Journal of Clinical Nutrition”. 57 (5 Suppl), s. 732S-736S, May 1993. PMID: 8386433. (ang.). 

nutrition.org

ajcn.nutrition.org

pharmacopola.pl

pwn.pl

sjp.pwn.pl

  • Cukrzyk. Słownik języka polskiego PWN. [dostęp 2010-10-20].
  • Diabetyk. Słownik języka polskiego PWN. [dostęp 2010-10-20].

unitefordiabetes.org

web.archive.org

worldcat.org